• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study on roles of angiostatic factor IP-10 and Mig in atherogenesis

Research Project

Project/Area Number 14570665
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionShimane University

Principal Investigator

OCHI Hiroshi  Shimane University, Faculty of Medicine, Department of Laboratory Medicine, Instructor, 医学部, 助手 (80204220)

Co-Investigator(Kenkyū-buntansha) TORII Ikuko  Shimane University, Faculty of Medicine, Department of Functional Pathology, Instructor, 医学部, 助手 (70207661)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 2003: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2002: ¥1,300,000 (Direct Cost: ¥1,300,000)
KeywordsAtherosclerosis / Immunology / IP-10 / Mig / I-Tac / ApoE deficient mouse / Ip-10
Research Abstract

IFN-inducible protein of 10 kDa (IP-10), IFN-inducible T cell α chemoattractant (I-Tac) and monokine induced by IFN-γ(Mig) are T cell directed CXC chemokines and also anti-angiogenic factors. We investigated roles of IP-10 in intimal neovascularization and atherogenesis in apoE deficient mice fed high cholesterol diet. Intimal neovascularization was evaluated using anti-CD31 Ab and anti-VWF Ab and rarely observed in mice,fed a high cholesterol diet for 30 weeks. We prepared rat anti mouse IP-10 monoclonal antibody (anti-IP-10 mAb) to block the action of IP-10 in apoE deficient mice. Mice were fed a high cholesterol diet from 6 weeks of age and subjected to intra-peritoneal injection of anti-IP-10 mAb (group 1) or PBS (group 2) from 12 weeks to 18 weeks twice a week. Intimal neovascularization was hardly seen in both groups. The mean area of advanced atherosclerotic lesions was similar in both groups. When 6-week-old mice were fed a high cholesterol diet and injected with anti-IP-10 mAb (group 3) or PBS (group 4) for 6 weeks, the mean area of early atherosclerotic lesion of group3 tended to be smaller than that of group 4. These results suggest that IP-10 may play a significant role during the development of early atherosclerotic lesion. However, the number of mice to be studied should be increased to confirm the difference between groups 3 and 4. In addition to animal study, regulation of IP-10, Mig and I-Tac gene expression in cultured endothelial cells was studied. We have reported that a bio-active phospholipid lysophosphatidylcholine (lysoPC) inhibits the interferon (IFN)-γ-induced gene expression of these chemokines in endothelial cells, suggesting immuno-moduratory role of lysoPC. In this project, we elucidated a mechanism responsible for the inhibitory effect of lysoPC : lysoPC inhibits the IFN-γ-induced gene expression of IP-10, Mig and I-Tac at post-transcriptional level

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] Ochi H: "Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity."European Journal of Immunology. 32. 1821-1831 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ochi H, et al.: "Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity"European Journal of Immunology. 32. 1821-1831 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ochi H: "Hyperrosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity"European Journal of Immunology. 32. 1821-1831 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi